modakafusp alfa
takeda
['modakafusp', 'mmsm', 'multiple myeloma']
modakafusp alfa has shown promising results as a single-agent therapy in patients with heavily pretreated multiple myeloma with an overall response rate of 39% and/or prior exposure to anti-bcma therapies with an overall response rate of 27% #ash22 #mmsm 
Supporting, educating and connecting myeloma patients and their loved ones while actively seeking a cure. #myeloma #mmsm #hematology #multiplemyeloma